Cerevel – Purdue Global Regulatory Sciences

The Cerevel – Purdue Global Regulatory Sciences Fellowship is a two year program that will provide the Doctor of Pharmacy graduate with personalized training and direct experience in Global Regulatory Sciences, focused on Regulatory Strategy in Neuroscience. The fellow will receive guidance and training from the Cerevel Global Regulatory Sciences team, support Global Regulatory Lead(s) on development activities, and work with drug development teams. The fellow will also have an academic focused rotation with Purdue University and have the opportunity to produce regulatory manuscript for publication(s). Our fellowship mission is to provide personalized training to develop leaders in drug development and biotechnology.

Cerevel Therapeutics is a new biopharmaceutical company formed by Bain Capital and Pfizer that relentlessly finds paths through complexity to bring real progress and new treatment options to people living with neurological and neuropsychiatric disorders. Cerevel aspires to develop and nurture a culture characterized by respect, trust, curiosity, compassion with a relentless focus on mission and results.  Our patient-centricity guides our purpose, how we treat each other and what we work on every day.